Press release
(February 24, 2025)
(February 4, 2025)
(February 3, 2025)
(January 28, 2025)
(September 23, 2024)
(August 28, 2024)
(May 13, 2024)
(April 30, 2024)
(April 18, 2024)
(February 21, 2024)
(February 5, 2024)
(November 2, 2023)
(November 1, 2023)
(May 24, 2023)
In the News
Vaccine Researcher: More Focus Needed On Potential Of mRNA
(Inside Health Policy: March 18, 2025)
RNA Medicines and Therapies Drive Healthcare Innovation
(Contagion: March 4, 2025)
Love of Science, CSUSM Fuels Alumnus at Local Biotech
(CSUCM News Center: February 17, 2025)
2025 Predictions for RNA Therapeutics
(The Medicine Maker: February 10, 2025)
The year ahead for RNA therapeutic development and manufacturing
(European Pharmaceutical Review: January 2, 2025)
Building up the infrastructure for future pandemic preparedness: Frontiers in rapid raw material production
(Pharmaceutical Technology: December 12, 2024)
Improving the Manufacture of mRNA Biologics
(Genetic Engineering & Biotechnology News: November 4, 2024)
“The future promise of mRNA is truly ushering in a new era of medicine.”
(PharmaVoice: October 8, 2024)
New $130M Sorrento Valley lab prepares US for future pandemics
(ABC10 News San Diego: August 21, 2024)
Not if, but when: Pandemic preparedness is crucial
(pharmaphorum: August 16, 2024)
mRNA Capping: A Component That Protects the COVID-19 Vaccine and Lends to its Effectiveness
(Contagion Live: August 11, 2024)
mRNA: Cap to the Future
(The Medicine Maker: July 19, 2024)
Opinion: Prepare Your Biopharma for the Next Pandemic, for Business and Global Good
(BioSpace: June 24, 2024)
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
(Business Wire: May 3, 2024)
Vaccine Developers Leverage mRNA and Other Powerful Technologies
(Genetic Engineering and Biotechnology News: May 1, 2024)
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
(Technology Networks: April 25, 2024)
What’s in store for mRNA therapeutics in 2024?
(PM360: March 27, 2024)
Ordinarily Extraordinary - Conversations with women in STEM
(Buzzsprout: March 27, 2024)
International Rare Disease Day
(Fox5 News San Diego: February 29, 2024)
TriLink BioTechnologies® Solidifies IP Position With Awarded Patents for CleanCap® Capping Technology in China & Canada
(Technology Networks: February 27, 2024)
The analytics advancements driving mRNA breakthroughs
(manufacturing CHEMIST: February 14, 2024)
Driving Breakthroughs in mRNA Therapeutics with Advanced Analytical Techniques
(American Pharmaceutical Review: February 1, 2024)
2024 pharma predictions: Therapeutic advances, manufacturing tech
(pharma Manufacturing: January 31, 2024)
Milestone Approval to Steady Stream, Gene Editing Revs Up
(BioPharm International: January 31, 2024)
Scrip Asks…What Does 2024 Hold For Biopharma? Part 4: Transformative Technology
(SCRIP Citeline: January 30, 2024)
Innovation Awards 2023: Voting Now Open
(The Medicine Maker: December 11, 2023)
The Shadow of COVID-19
(The Medicine Maker: November 27, 2023)
Medicine’s Hot New Modality, mRNA, Faces Unclear Regulatory Landscape
(BioSpace: October 25, 2023)
The Bright Future of mRNA Vaccines
(ID Transmission: October 9, 2023)
Realizing the Promise of mRNA Tech to Revolutionize Global Health
(Today's Clinical Lab: October 3, 2023)
An Interview with Jason Downing, Sr Product Manager, Trilink BioTechnologies
(American Pharmaceutical Review: October 1, 2023)
Pharma Manufacturing announces the 2023 Pharma Innovation Award winners
(pharma Manufacturing: September 26, 2023)
Optimizing mRNA therapeutics
(pharma Manufacturing: August 31, 2023)
The Top 25 Companies of San Diego for 2023
(The Business Report: August 28, 2023)
Manufacturing key to overcoming the next pandemic
(Pharmaforum: August 23, 2023)
Contact
CG Life
Email: trilink@cglife.com
Phone: 847-702-8099